Last $0.09 USD
Change Today -0.0009 / -1.01%
Volume 44.1K
NNLX On Other Exchanges
As of 11:50 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

nanologix inc (NNLX) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/3/13 - $0.20
52 Week Low
08/19/14 - $0.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOLOGIX INC (NNLX)

Related News

No related news articles were found.

nanologix inc (NNLX) Related Businessweek News

No Related Businessweek News Found

nanologix inc (NNLX) Details

NanoLogix, Inc., a biotechnology company, provides medical research and development services. The company researches, develops, and produces diagnostic products to detect viable bacteria and other microorganisms. Its products include BioNanoPore test kits that employ water permeable membrane and can be utilized by various other nutrient agars; BioNanoFilter, which builds on the detection power of the BioNanoPore technology to detect and identify live-cell microorganisms in both small and large-volume samples; and Quick Test kits that detect and identify the growth of various bacteria and yeasts. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.

nanologix inc (NNLX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanologix inc (NNLX) Key Developments

NanoLogix Inc. Announces Executive Changes

NanoLogix Inc. announced that William "Hank" Lewis has accepted the newly created position of Vice President of Sales and Marketing for NanoLogix products. In a release, the Company said that Lewis brings extensive sales and marketing expertise to the position, in a sales career spanning three decades, having most recently worked for CardioDx as Regional Sales Manager, preceded by roles as Regional Sales Manager with Myriad Genetics, Novartis Pharmaceuticals, and Knoll Pharmaceuticals for sales over multistate regions. The company also announced the promotion of Michelle Durkin to the position of Director of Laboratory Operations and New Product Development.

NanoLogix Inc. Signs Asia Distribution Agreement with IVD Tech Private Ltd

NanoLogix Inc. announced that they have signed a distribution agreement with IVD Tech Private Ltd. of Singapore. This distribution agreement provides IVD Tech with exclusive distribution rights for sales of NanoLogix products in a number of Asian countries. The agreement was finalized and signed in Hubbard Ohio with the help of Mousa Kassis, representative of the Ohio International Trade Assistance Center (ITAC) housed at Youngstown State University. In addition to a growing market presence in the United States, NanoLogix currently has business relationships in nine countries on four continents.

NanoLogix and Nasaem-Aljazira to Work Together for Distribution of Nanologix Products in the Arabian Gulf Region

NanoLogix Inc. announced that they are working with Nasaem-Aljazira to establish exclusive distribution and/or manufacturing of NanoLogix products in Saudi Arabia and the Arabian Gulf region, also known as the Gulf Cooperation Council (GCC) area. This area offers a large market potential to Nasaem-Aljazira and NanoLogix, with Saudi Arabia being a leader in advanced health care initiatives for its people.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NNLX:US $0.09 USD -0.0009

NNLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NNLX.
View Industry Companies

Industry Analysis


Industry Average

Valuation NNLX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8,358.4x
Price/Book 11.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3,173.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOLOGIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at